p53 modulation of TFIIH–associated nucleotide excision repair activity

Nature Genetics

Volumn 10, Issue 2, 1995, Pages 188-195

  Wang, X W ^a   Yeh, H ^a   Schaeffer, L ^b   Roy, R ^b   Moncollin, V ^b   Egly, J M ^b   Wang, Z ^c   Friedberg, E C ^c   Evans, M K ^d   Taffe, B G ^d   Bohr, V A ^d   Weeda, G ^e   Hoeijmakers, J H J ^e   Forrester, K ^a   Harris, C C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INSERM   (France)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HELICASE; PROTEIN P53; TRANSCRIPTION FACTOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVITY; EXCISION REPAIR; FAMILIAL CANCER; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ADENOSINETRIPHOSPHATASE; AMINO ACID SEQUENCE; CHROMOSOME MAPPING; COCKAYNE SYNDROME; DNA HELICASES; DNA REPAIR; DNA-BINDING PROTEINS; ENZYME ACTIVATION; HUMAN; LI-FRAUMENI SYNDROME; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEOTIDES; PROTEIN P53; PROTEIN STRUCTURE, SECONDARY; PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; XERODERMA PIGMENTOSUM;

EID: 0028989236     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng0695-188     Document Type: Article

References (61)

1. Cleaver, J. E. Defective repair replication of DNA in xeroderma pigmentosum. Nature 218, 652-656 (1968).
2. Satoh, M. S., Jones, C. J., Wood, R. D. & Lindahl, T. DNA excision-repair defect of xeroderma pigmentosum prevents removal of a class of oxygen free radical-induced base lesions. Proc. natn. Acad. Sci U. S. A. 90, 6335-6339 (1993).
3. Cleaver, J. E. & Kraemer, K. H. The Metabolic Basis of Inherited Disease 7th edn (McGraw-Hill, New York, 1994).
4. Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233-1238 (1990).
5. Donehower, L. A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221 (1992).
6. Livingstone, L. R. et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923-935 (1992).
7. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C. & Wahl, G. M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70, 937-948 (1992).
8. Greenblatt, M. S., Bennett, W. P., Hollstein, M. & Harris, C. C. Mutations in the p53 tumour suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878 (1994).
9. Kastan, M. B. et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia-Telangiectasia. Cell 71, 587-597 (1992).
10. Lu, X. & Lane, D. P. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75, 765-778 (1993).
11. El-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumour suppression. Cell 75, 817-825 (1993).
12. Zhan, Q. et al. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Molec. cell Biol. 14, 2361-2371 (1994).
13. Okamoto, K. & Beach, D. Cyclin G is atranscriptional target of the p53 tumour suppressor protein. EMBO J 13, 4816-4822 (1994).
14. Waga, S., Hannon, G. J., Beach, D. & Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369, 574-578 (1994).
15. Yonish-Rouach, E. et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352, 345-347 (1991).
16. Wang, X. W. et al. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. natn. Acad. Sci U. S. A. 91, 2230-2234 (1994).
17. Schaeffer, L. et al. DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science 260, 58-63 (1993).
18. Schaeffer, L. et al. The ERCC2/DNA repair protein is associated with the class II BTF2/TFIIH transcription factor. EMBO J. 13, 2388-2392 (1994).
19. Fischer, L. et al. Cloning of the 62-kilodalton component of basic transcription factor BTF2. Science 257, 1392-1395 (1992).
20. Humbert, S. et al. p44 and p34 subunits of the BFT2/TFIIH transcription factor have homologies with SSL1, a yeast protein involved in DNA repair. EMBO J. 13, 2393-2398 (1994).
21. Roy, R. et al. The DNA-dependent ATPase activity associated with the class II basic transcription factor BTF2/TFIIH. J biol. Chem 269, 9826-9832 (1994).
22. Goodrich, J. A. & Tjian, R. Transcription factors ME and IIH and ATP hydrolysis direct promoter clearance by RNA polymerase II. Cell 77, 145-156 (1994).
23. Drapkin, R. et al. Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II. Nature 368, 769-772 (1994).
24. Weeda, G. et al. A presumed DNA helicase encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne’s syndrome. Cell 62, 777-791 (1990).
25. Flejter, W. L., McDaniel, L. D., Johns, D., Friedberg, E. G. & Schultz, R. A. Correction of xeroderma pigmentosum complementation group D mutant cell phenotypes by chromosome and gene transfer: involvement of the human ERCC2 DNA repair gene. Proc. natn. Acad. Sci U. S. A. 89, 261-265 (1992).
26. Venema, J., Mullenders, L. H., Natarajan, A. T., Van Zeeland, A. A. & Mayne, L. V. The genetic defect in Cockayne syndrome is associated with a defect in repair of UV-induced DNA damage in transcriptionally active DNA. Proc. natn. Acad. Sci U. S. A. 87, 4707-4711 (1990).
27. Vermeulen, W., Stefanini, M., Giliani, S., Hoeijmakers, J. H. & Bootsma, D. Xeroderma pigmentosum complementation group H falls intoo complementation group D. Mutat. Res. 255, 201-208 (1991).
28. Troelstra, C. et al. ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne’s syndrome and preferential repair of active genes. Cell 71, 939-953 (1992).
29. Ma, L. et al. Mutational analysis of ERCC3, which is involved in DNA repair and transcription initiation: identification of domains essential for the DNA repair function. Molec. cell. Biol. 14, 4126-4134 (1994).
30. Bartek, J., Vojtësek, B. & Lane, D. P. Diversity of human p53 mutants revealed by complex formation to SV40 T antigen. Eur. J. Cancer. 29A, 101-107 (1992).
31. Huibregtse, J. M., Scheffner, M. & Howley, P. M. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Molec. Cell. Biol. 13, 775-784 (1993).
32. Xiao, H. et al. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Molec. cell. Biol. 14, 7013-7024 (1994).
33. Seto, E. et al. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. natn. Acad. Sci. U. S. A. 89, 12028-12032 (1992).
34. Thut, C. J., Chen, J.-L., Klemm, R. & Tjian, R. p53 transcriptional activation mediated by coactivators TAFH40 and TAFH60. Science 267, 100-104 (1995).
35. Chou, P. Y., chou, P. Y & Fasman, G. D. Prediction of protein conformation. Biochemistry 13, 222-245 (1974).
36. Garnier, J., Osguthorpe, D. J. & Robson, B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J. molec. Biol. 120, 97-120 (1978).
37. Braithwaite, A. W. et al. Mouse p53 inhibits SV40 origin-dependent DNA replication. Nature 329, 458-460 (1987).
38. Wang, E. H., Friedman, P. N. & Prives, C. The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen. Cell. 57, 379-392 (1989).
39. Oberosler, P., Hloch, P., Ramsperger, U. & Stahl, H. p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO J. 12, 2389-2396 (1993).
40. Bakalkin, G. et al. p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc. natn. Acad. Sci. U. S. A. 91, 413-417 (1994).
41. Evans, M. K. et al. Gene-specific DNA repair in xeroderma pigmentosum complementation groups A, C, D, and F. Relation to cellular survival and clinical features. J. biol. Chem. 268, 4839-4847 (1993).
42. Dittmer, D. et al. Gain of function mutations in p53. Nature Genet. 4, 42-46 (1993).
43. Hodgman, T. C. A new superfamily of replicative proteins. Nature 333, 22-23 (1988).
44. Sakurai, T., Suzuki, M., Sawazaki, T., Ishii, S. & Yoshida, S. Anti-oncogene product p53 binds DNA helicase. Exp. Cell Res. 215, 57-62 (1994).
45. Hupp, T. R., Meek, D. W., Midgley, C. A. & Lane, D. P. Regulation of the specific DNA binding function of p53. Cell 71, 875-886 (1992).
46. Hupp, T. R. & Lane, D. P. Allosteric activation of latent p53 tetramers. Curr. Biol. 4, 865-875 (1995).
47. Kulesz-Martin, M. F., Lisafeld, B., Huang, H., Kisiel, N. D. & Lee, L. Endogenous p53 protein generated from wild-type alternatively spliced p53 RNA in mouse epidermal cells. Molec. cell. Biol. 14, 1698-1708 (1994).
48. Wu, L., Bayle, J. H., Elenbaas, B., Pavletich, N. P. & Levine, A. J. Alternatively spliced forms in the carboxy-terminal domain of the p53 protein regulate its ability to promote annealing of complementary single strands of nucleic acids. Molec. cell. Biol. 15, 497-504 (1995).
49. Stahl, H., Droge, P. & Knippers, R. DNA helicase activity of SV40 large tumour antigen. EMBO J. 5, 1939-1944 (1986).
50. Smith, M. L., Chen, I. T., Zhan, Q., O’Connor, P. M. & Fornace, A. J. Jr. Involvement of the p53 tumour suppressor in repair of UV-type DNA damage. Oncogene (In the press) (1995).
51. Li, L., Elledge, S. J., Peterson, C. A., Bales, E. S. & Legerski, R. J. Specific association between the human DNA repair proteins XPA and ERCC1. Proc. natn. Acad. Sci. U. S. A. 91, 5012-5016 (1994).
52. McWhir, J., Selfridge, J., Harrison, D. J., Squires, S. & Melton, D. W. Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Nature Genet. 5, 217-224 (1993).
53. Wilcock, D. & Lane, D. P. Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells. Nature 349, 429-431 (1991).
54. Dutta, A., Ruppert, J. M., Aster, J. C. & Winchester, E. Inhibition of DNA replication factor RPA by p53. Nature 365, 79-82 (1993).
55. Amundson, S. A., Xia, F., Wolfson, K. & Liber, H. L. Different cytoxic and mutagenic responses induced by X-rays in two human lymphoblastoid cell lines derived from a single donor. Mut. Res. 286, 233-241 (1993).
56. Little, J. B., Nagasawa, H., Keng, P. C., Yu, Y. & Li, C.-Y. Absence of radiation-induced G1 arrest in two closely related human lymphoblast cell lines that differ in p53 status. J. biol. Chem. 270, 1-5 (1995).
57. Kawashima, K., Mihara, K., Usuki, H., Shimizu, N. & Namba, M. Transfected mutant p53 gene increases X-ray-induced cell killing and mutation in human fibroblasts immortalized with 4-nitroquinoline 1-oxide but does not induce neoplastic transformation of the cells. Int. J. Cancer61, 76-79 (1995).
58. Ruppert, J. M. & Stillman, B. Analysis of a protein-binding domain of p53. Molec. cell. Biol. 13, 3811-3820 (1993).
59. Naegeli, H., Bardwell, L. & Friedberg, E. G. The DNA helicase and adenosine triphosphatase activities of yeast Rad3 protein are inhibited by DNA damage. A potential mechanism for damage-specific recognition. J. biol. Chem 267, 392-398 (1992).
60. Srivastava, S., Zou, Z. Q., Pirollo, K., Blattner, W. & Chang, E. H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348, 747-749 (1990).
61. Bohr, V. A. & Okumoto, D. S. Analysis of DNA repair in defined genomic sequences. DNA Repair, A Manual of Research Procedures. (eds Hanawalt, P. C. & Friedberg, E. G.) 347-366 (Marcel Dekker, New York, 1988).